Olema Pharmaceuticals annual current ratio
2020
2021
2022
2023
2024
2025
Olema Pharmaceuticals Current Ratio Growth & History (OLMA)
Olema Pharmaceuticals's current ratio was 9.95 for fiscal 2025.
View full Olema Pharmaceuticals company overviewOlema Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 9.95 | −0.55 | −5.24% |
| 2024 | 2024-12-31 | 10.50 | −1.83 | −14.82% |
| 2023 | 2023-12-31 | 12.33 | −0.30 | −2.35% |
| 2022 | 2022-12-31 | 12.62 | −19.61 | −60.83% |
| 2021 | 2021-12-31 | 32.23 | −42.39 | −56.81% |
| 2020 | 2020-12-31 | 74.62 | — | — |
Olema Pharmaceuticals quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.86 | −2.22 | −20.07% |
| Q1 2026 | 2026-03-31 | 10.88 | −4.34 | −28.50% |
| Q4 2025 | 2025-12-31 | 9.95 | −0.55 | −5.24% |
| Q3 2025 | 2025-09-30 | 8.03 | 0.93 | +13.03% |
| Q2 2025 | 2025-06-30 | 11.09 | 1.96 | +21.49% |
| Q1 2025 | 2025-03-31 | 15.22 | 5.61 | +58.32% |
| Q4 2024 | 2024-12-31 | 10.50 | −1.83 | −14.82% |
| Q3 2024 | 2024-09-30 | 7.10 | −10.56 | −59.80% |
| Q2 2024 | 2024-06-30 | 9.13 | −2.44 | −21.07% |
| Q1 2024 | 2024-03-31 | 9.61 | −0.14 | −1.48% |
| Q4 2023 | 2023-12-31 | 12.33 | −0.30 | −2.35% |
| Q3 2023 | 2023-09-30 | 17.66 | −0.27 | −1.49% |
| Q2 2023 | 2023-06-30 | 11.56 | −8.18 | −41.43% |
| Q1 2023 | 2023-03-31 | 9.76 | −16.82 | −63.28% |
| Q4 2022 | 2022-12-31 | 12.62 | −19.61 | −60.83% |
| Q3 2022 | 2022-09-30 | 17.93 | −16.70 | −48.23% |
| Q2 2022 | 2022-06-30 | 19.75 | −19.64 | −49.87% |
| Q1 2022 | 2022-03-31 | 26.57 | −36.01 | −57.54% |
| Q4 2021 | 2021-12-31 | 32.23 | −42.39 | −56.81% |
| Q3 2021 | 2021-09-30 | 34.63 | — | — |
| Q2 2021 | 2021-06-30 | 39.39 | — | — |
| Q1 2021 | 2021-03-31 | 62.59 | — | — |
| Q4 2020 | 2020-12-31 | 74.62 | — | — |
Olema Pharmaceuticals current ratio trends
Over the last five fiscal years, Olema Pharmaceuticals's current ratio decreased from 74.62 to 9.95, a change of −64.67. The latest reported quarter, Q2 2026, shows 8.86.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Olema Pharmaceuticals source filings ↗